ghk-cu subcutaneous dosing FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR GHK-CU Peptide Dosage Chart: Complete

They should not be used outside of approved research plans

As soon as we have your tracking number, we will email you

What were building Neurophorol to enable (research-stage endpoints): receptor/pathway profiling + SAR learning neuroimmune and inflammation readouts oxidative stress / resilience markers reproducible preclinical validation workflows Were opening collaboration discussions with teams who can help validate and translate this platform responsibly: (Universities, Biotech companies, Tribal communities, and Investors) CB1/CB2 functional assays + signaling bias analytical chemistry (LCMS/NMR) + stability profiling neuroimmune models (microglia), biomarkers, preclinical design ADME/PK and translational study frameworks If you work in this space, comment NEUROPHOROL or DM your capability stack

Smits RM, Veldhuijzen DS, Wulffraat NM, Evers AWM

While animal models have shown a favorable safety profile, and many individuals report positive experiences, the absence of extensive human clinical trials means that caution is advised